Skip to main navigation Skip to search Skip to main content

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

  • William J. Gradishar
  • , Benjamin O. Anderson
  • , Ron Balassanian
  • , Sarah L. Blair
  • , Harold J. Burstein
  • , Amy Cyr
  • , Anthony D. Elias
  • , William B. Farrar
  • , Andres Forero
  • , Sharon H. Giordano
  • , Matthew P. Goetz
  • , Lori J. Goldstein
  • , Steven J. Isakoff
  • , Janice Lyons
  • , P. Kelly Marcom
  • , Ingrid A. Mayer
  • , Beryl McCormick
  • , Meena S. Moran
  • , Ruth M. O’Regan
  • , Sameer A. Patel
  • Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda L. Telli, John H. Ward, Rashmi Kumar, Dorothy A. Shead

Research output: Contribution to journal › Article › peer-review

339 Scopus citations

Abstract

Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This manuscript focuses on the NCCN Guidelines Panel recommendations for the workup, primary treatment, risk reduction strategies, and surveillance specific to DCIS.

Original languageEnglish
Pages (from-to)310-320
Number of pages11
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume16
Issue number3
DOIs
StatePublished - Mar 1 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this